SCHEMBL20445713

SCHEMBL20445713

CC(C)(C)OC(=O)N1CC[C@H](n2cc(Nc3nccc(-c4ccc(CNC(=O)N5CC[C@@H](C(C)(C)C)C5)c(C(F)(F)F)c4)n3)cn2)C1

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 16/20 0.63
▸ CD69 Q07108 2/20 0.49
▸ JAK2 O60674 2/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ HRH2 P25021 1/20 0.47
▸ CDK7 P50613 1/20 0.47
▸ AAK1 Q2M2I8 1/20 0.47
▸ MAP3K19 Q56UN5 1/20 0.47
▸ CDKL2 Q92772 1/20 0.47
▸ RIOK1 Q9BRS2 1/20 0.47
▸ RIOK2 Q9BVS4 1/20 0.47
▸ BMP2K Q9NSY1 1/20 0.47
▸ EPHX2 P34913 1/20 0.40
▸ JAK3 P52333 1/20 0.40
▸ PTK2 Q05397 1/20 0.40
▸ FLT4 P35916 1/20 0.40
▸ MAP4K1 Q92918 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16794488 1.00 BTK (0.63) BTKCD69JAK2CYP3A4HRH2
SCHEMBL16794487 1.00 BTK (0.63) BTKCD69JAK2CYP3A4HRH2
SCHEMBL18170391 0.92 BTK (0.70) BTKCD69JAK2CYP3A4HRH2
SCHEMBL29676669 0.91 BTK (0.68) BTKCD69JAK2CYP3A4HRH2
SCHEMBL16794360 0.91 BTK (0.68) BTKCD69JAK2CYP3A4HRH2
SCHEMBL16794456 0.91 BTK (0.68) BTKCD69JAK2CYP3A4HRH2
SCHEMBL16794458 0.91 BTK (0.68) BTKCD69JAK2CYP3A4HRH2
SCHEMBL16794059 0.91 BTK (0.69) BTKCD69JAK2CYP3A4HRH2
SCHEMBL16794252 0.90 BTK (0.70) BTKCD69JAK2CYP3A4HRH2
SCHEMBL29676473 0.89 BTK (0.65) BTKCD69JAK2CYP3A4HRH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3357921-A2 BIARYL COMPOUNDS USEFUL FOR THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEUROLOGY AND IMMUNOLOGY Sunesis Pharmaceuticals, Inc. (US) 2018-08-08 — — EP disclosed
Send feedback